Epi-lipoxin

Revision as of 17:09, 4 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Epi-lipoxins are the 5R-epimers of lipoxins. These nonclassic eicosanoids are formed in vivo, in the presence of aspirin.[1] They play a counter-regulatory role in inflammation, serving as a stop signal.[2]

References

  1. Clària J, Serhan CN (1995). "Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions". Proc. Natl. Acad. Sci. U.S.A. 92 (21): 9475–9. PMID 7568157. Retrieved 2007-11-01.
  2. Serhan CN (2001). "Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side". Arch. Immunol. Ther. Exp. (Warsz.). 49 (3): 177–88. PMID 11478391. |access-date= requires |url= (help)

Template:Eicosanoids

Template:WikiDoc Sources